However, in addition to the immunological activity of FcRn involving IgG interactions and antigen presentation [25–27], our studies demonstrate that the levels of this receptor within the tumor cells themselves modulate cancerous growth by regulating albumin accumulation. The gene discussed is ALB; the disease is neoplasm.